Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses
Griffithsin (GRFT), a lectin from Griffithsia species, inhibits human immunodeficiency virus-1 (HIV-1) replication at sub-nanomolar concentrations, with limited cellular toxicity. However, in vivo safety of GRFT is not fully understood, especially following parenteral administration. We first assess...
Main Authors: | Joseph Calvin Kouokam, Amanda B. Lasnik, Kenneth E. Palmer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/8/11/311 |
Similar Items
-
Technoeconomic Modeling of Plant-Based Griffithsin Manufacturing
by: Aatif Alam, et al.
Published: (2018-07-01) -
In Preparation for Outdoor Pharming: Griffithsin Can Be Expressed in Nicotiana excelsiana and Retains Activity After Storage as Silage
by: Paul Eapen, et al.
Published: (2020-03-01) -
Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin
by: Henry W. Nabeta, et al.
Published: (2021-10-01) -
Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis
by: Henry W. Nabeta, et al.
Published: (2022-10-01) -
In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection
by: Minooei F, et al.
Published: (2021-02-01)